Filing Details

Accession Number:
0000914190-19-000420
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-25 16:25:10
Reporting Period:
2019-11-21
Accepted Time:
2019-11-25 16:25:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603594 James Hippel 614 Mckinley Place N.e.
Minneapolis MN 55413
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-21 11,349 $94.35 20,656 No 4 M Direct
Common Stock Disposition 2019-11-21 11,349 $215.36 9,307 No 4 S Direct
Common Stock Acquisiton 2019-11-22 23,651 $94.35 32,958 No 4 M Direct
Common Stock Disposition 2019-11-22 22,051 $215.55 10,907 No 4 S Direct
Common Stock Disposition 2019-11-22 1,600 $216.16 9,307 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2019-11-21 11,349 $0.00 11,349 $94.35
Common Stock Stock Options (Right to Buy) Disposition 2019-11-22 23,651 $0.00 23,651 $94.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,651 2021-08-21 No 4 M Direct
0 2021-08-12 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $108.49 2022-08-07 25,000 25,000 Direct
Common Stock Stock Options (Right to Buy) $108.49 2022-08-07 14,988 14,988 Direct
Common Stock Stock Options (Right to Buy) $106.59 2023-08-18 30,400 30,400 Direct
Common Stock Stock Options (Right to Buy) $106.59 2023-08-18 40,533 40,533 Direct
Common Stock Restricted Stock Units $0.00 4,438 4,438 Direct
Common Stock Stock Options (Right to Buy) $125.05 2024-08-09 24,460 24,460 Direct
Common Stock Stock Options (Right to Buy) $125.05 2024-08-09 32,613 32,613 Direct
Common Stock Restricted Stock Units $0.00 3,383 3,383 Direct
Common Stock Stock Options (Right to Buy) $177.32 2025-08-08 18,066 18,066 Direct
Common Stock Stock Options (Right to Buy) $177.32 2025-08-08 24,089 24,089 Direct
Common Stock Restricted Stock Units $0.00 3,938 3,938 Direct
Common Stock Stock Options (Right to Buy) $190.41 2026-08-07 19,936 19,936 Direct
Common Stock Stock Options (Right to Buy) $190.41 2026-08-07 26,581 26,581 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-08-07 25,000 25,000 Direct
2022-08-07 14,988 14,988 Direct
2023-08-18 30,400 30,400 Direct
2023-08-18 40,533 40,533 Direct
4,438 4,438 Direct
2024-08-09 24,460 24,460 Direct
2024-08-09 32,613 32,613 Direct
3,383 3,383 Direct
2025-08-08 18,066 18,066 Direct
2025-08-08 24,089 24,089 Direct
3,938 3,938 Direct
2026-08-07 19,936 19,936 Direct
2026-08-07 26,581 26,581 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.00 to $215.84, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.00 to $215.9956, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.01 to $216.20, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
  5. Fully exercisable.
  6. Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020.
  7. Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  8. Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021.
  9. Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  10. Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.
  11. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  12. Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.